Nokea
Nurse Victoria is teaching the parents of a school-age child. Which teaching topic should take priority?
- A. Prevent accidents
- B. Keeping a night light on to allay fears
- C. Explaining normalcy of fears about body integrity
- D. Encouraging the child to dress without help
Correct Answer: A
Rationale: Accident prevention is a priority for school-age children as they become more independent and engage in activities that may pose risks.
You may also like to solve these questions
In the electrocardiogram of a 40-year old male, the QRS amplitude in lead I and aVF measured (+) 10 and (-)10mV respectively. The frontal QRS axis is
- A. (+) 15°
- B. (-) 45°
- C. (-) 75°
- D. (-) 90°
Correct Answer: B
Rationale: The frontal QRS axis is (-) 45° given the QRS amplitudes in leads I and aVF.
The treatment of choice for the lesion of the neonate is
- A. digoxin
- B. propranolol (Inderal)
- C. surgical shunt
- D. balloon valvuloplasty
Correct Answer: D
Rationale: Balloon valvuloplasty can relieve pulmonary stenosis and improve symptoms in Tetralogy of Fallot.
Clinical manifestations of haemophilia include:
- A. Bleeding following neonatal intramuscular injection
- B. Intracranial bleeding
- C. Gingival bleeding
- D. Menorrhagia
Correct Answer: B
Rationale: Intracranial bleeding is a serious and potentially life-threatening manifestation of hemophilia, particularly in severe cases.
Pulmonary stenosis
- A. Most common at pulmonary valve level
- B. Valve dilatation done for dysplastic valves
- C. Ejection click occurs in past stenotic dilatation
- D. Surgery done when Rt ventricular pressure exceeds 25 mmHg
Correct Answer: A
Rationale: Pulmonary stenosis is most commonly found at the pulmonary valve level.
Accepted maintenance treatment for chronic asthma includes the following:
- A. High-dose inhaled steroids and long-acting bronchodilators
- B. Montelucast
- C. Montelucast and inhaled steroids
- D. Long-acting ~2-agonists alone
Correct Answer: A
Rationale: The correct answer is A because high-dose inhaled steroids and long-acting bronchodilators are the mainstay of chronic asthma management. The other options (b-e) are less commonly used or not first-line.